Skip to main content

Web Exclusives

COVID-19

Patient Advocacy During the Pandemic

CMS Expands Access to Telehealth Benefits During COVID-19 Outbreak

Ovarian Cancer, PARP Inhibitors

Key Clinical and Operational Considerations in Practice-Based Dispensing of PARP Inhibitors and Other Oral Oncology Agents

Ovarian Cancer

ASCO Updates Its Oncology Medical Home Payment Model

Ovarian Cancer

Pooled Analysis Finds No Definitive Link Between Talc-Based Powders and Ovarian Cancer

Supportive Care

Steroids plus Exercise Reduce Fatigue in Patients with Advanced Cancer

Meeting Highlights

ESMO Highlights

Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations

Meeting Highlights

ESMO Highlights

Ceritinib Effective in Treating Brain Metastases in NSCLC

Meeting Highlights

ESMO Highlights, PARP Inhibitors

Paradigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian Cancer

Biosimilars

Best Practices for Integrating Biosimilars into Your Oncology Practice

Kashyap Patel, MD

Page 18 of 43
Results 171 - 180 of 425